Idioma:

Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer

Sparano, Joseph A ; Gray, Robert J ; Ravdin, Peter M ; Makower, Della F ; Pritchard, Kathleen I ; Albain, Kathy S ; Hayes, Daniel F ; Geyer, Charles E ; Dees, Elizabeth C ; Goetz, Matthew P ; Olson, John A ; Lively, Tracy ; Badve, Sunil S ; Saphner, Thomas J ; Wagner, Lynne I ; Whelan, Timothy J ; Ellis, Matthew J ; Paik, Soonmyung ; Wood, William C ; Keane, Maccon M ; Gomez Moreno, Henry L ; Reddy, Pavan S ; Goggins, Timothy F ; Mayer, Ingrid A ; Brufsky, Adam M ; Toppmeyer, Deborah L ; Kaklamani, Virginia G ; Berenberg, Jeffrey L ; Abrams, Jeffrey ; Sledge, George W

The New England journal of medicine, 2019-06, Vol.380 (25), p.2395-2405 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por

Enviar para

Título:
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer
Autor: Sparano, Joseph A ; Gray, Robert J ; Ravdin, Peter M ; Makower, Della F ; Pritchard, Kathleen I ; Albain, Kathy S ; Hayes, Daniel F ; Geyer, Charles E ; Dees, Elizabeth C ; Goetz, Matthew P ; Olson, John A ; Lively, Tracy ; Badve, Sunil S ; Saphner, Thomas J ; Wagner, Lynne I ; Whelan, Timothy J ; Ellis, Matthew J ; Paik, Soonmyung ; Wood, William C ; Keane, Maccon M ; Gomez Moreno, Henry L ; Reddy, Pavan S ; Goggins, Timothy F ; Mayer, Ingrid A ; Brufsky, Adam M ; Toppmeyer, Deborah L ; Kaklamani, Virginia G ; Berenberg, Jeffrey L ; Abrams, Jeffrey ; Sledge, George W
Assuntos: Adjuvant therapy ; Adjuvants ; Adult ; Age ; Age Factors ; Aged ; Algorithms ; Antineoplastic Agents, Hormonal - therapeutic use ; Breast cancer ; Breast Neoplasms - drug therapy ; Breast Neoplasms - genetics ; Breast Neoplasms - surgery ; Cancer therapies ; Chemotherapy ; Chemotherapy, Adjuvant ; Clinical trials ; Confidence intervals ; Disease-Free Survival ; Endocrine therapy ; Epidermal growth factor ; Estrogen Antagonists - therapeutic use ; Female ; Gene Expression Profiling ; Humans ; Medical prognosis ; Medical research ; Middle Aged ; Neoplasm Recurrence, Local - genetics ; Neoplasm Recurrence, Local - prevention & control ; Oncology ; Premenopause ; Prognosis ; Proportional Hazards Models ; Prospective Studies ; Receptor, ErbB-2 ; Risk Factors ; Statistical analysis ; Tamoxifen ; Tamoxifen - therapeutic use ; Womens health
É parte de: The New England journal of medicine, 2019-06, Vol.380 (25), p.2395-2405
Notas: ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-News-2
ObjectType-Feature-3
content type line 23
Descrição: TAILORx established the role of the 21-gene predictor of genetic risk in ascertaining treatment for women with hormone-receptor–positive, human epidermal growth factor receptor 2–negative breast cancer. Clinical risk factors provided additional prognostic information for women with intermediate genetic risk.
Editor: United States: Massachusetts Medical Society
Idioma: Inglês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Anterior Resultado 9 Avançar Ir para próxima página

Realização: Logos de Redes Sociais:

Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer

United States: Massachusetts Medical Society

Buscando em bases de dados remotas. Favor aguardar.